Paula Peixoto-Moledo

Paula Peixoto-Moledo

Auto-generated profile, based on publicly available information

Paula Peixoto-Moledo

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2018 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
MCMahdi Chaari
Mahdi Chaari
NGNerea Gaztelumendi
Nerea Gaztelumendi
JCJusto Cabrera-González
Justo Cabrera-González
PPPaula Peixoto-Moledo
Paula Peixoto-Moledo
ICMAB-CSIC Viñas TeixidorICMAB-CSIC Viñas Teixidor
ICMAB-CSIC Viñas Teixidor
RNRosario Nuñez
Rosario Nuñez

25 November 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
AZAmirPasha Zamani
AmirPasha Zamani
PPPaula Peixoto-Moledo
Paula Peixoto-Moledo
DTDavid P. Tomàs
David P. Tomàs
HRHoracio G. Rotstein
Horacio G. Rotstein
JDJosep Dalmau
Josep Dalmau
PJPablo E. Jercog
Pablo E. Jercog
N-methyl D-aspartate receptor (NMDAR) encephalitis is an immune-mediated disorder characterized by a complex neuropsychiatric syndrome together with a reduction of NMDAR. Although in most patients the life-threatening symptoms of the acute stage resolve with immunotherapy, memory and executive functions remain altered for several months or years. A mechanistic explanation for these long-lasting cognitive effects is still lacking and previous animal models have not explored this effect. Here, we combined repeat calcium imaging of the same population of hundreds of hippocampal CA1 neurons for three months along with two behavioral tasks to assess retrograde and anterograde memory loss using a reported mouse model of cerebroventricular transfer of patients’ CSF antibodies. We measured how memory-related neuronal activity is affected by the presence of NMDAR antibodies during the induction of the model and its long-lasting recovery. In addition, we developed a computational model that provides a mechanistic explanation for the long-term antibody-mediated impairment of memory. The findings show that the presence of antibodies leads to an increase of CA1 neuronal firing rate, resulting in a reduction of the amount of information encoded by these cells. Furthermore, the antibodies cause a degradation of the hippocampal neuronal response stability over time, providing a neural correlate of memory dysfunction. All these neuronal alterations span the 3 months of recordings, and in some cases beyond the last recording point. The computational model shows that a reduction of NMDAR is sufficient to cause the changes observed in neuronal activity, including the different involvement of excitatory and inhibitory inputs to CA1 neurons. Altogether, we show that the antibody-mediated reduction of NMDAR leads to long-term changes in hippocampal neuronal activity which extend far beyond the antibody clearance, providing a mechanism that can account for the cognitive deficits observed in the protracted recovery of patients with anti-NMDAR encephalitis.

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
PPPaula Peixoto-Moledo
Paula Peixoto-Moledo
SBSamiul Basar
Samiul Basar
JDJosep Dalmau
Josep Dalmau
YAYashar Ahmadian
Yashar Ahmadian
PJPablo Jercog
Pablo Jercog